One thing is likely to hurt some medtech companies more than others during the coronavirus pandemic: an elective surgical procedure slowdown. This thought had begun to emerge last week among industry watchers, but a pair of tweets over the weekend gained thousands of “likes” and retweets. The American College of Surgeons called for hospitals to […]
Johnson & Johnson
Johnson & Johnson: Clinical study of potential coronavirus vaccine could start by end of year
Johnson & Johnson (NYSE:JNJ) said today that its Janssen Pharmaceutical Cos. has forged a partnership with the Beth Israel Deaconess Medical Center (BIDMC) to support coronavirus vaccine development. Janssen and the virology lab led by Dr. Dan Barouch at BIDMC have started preclinical testing of multiple vaccine prospects, with the goal of identifying a COVID-19 […]
Medical device company stocks aren’t immune from coronavirus
Major U.S. medical device company stocks have generally performed as poorly as others over the past two weeks as the global coronavirus outbreak drive markets down. Among 20 of the largest U.S. companies on Medical Design & Outsourcing and MassDevice‘s annual Big 100 list, both the average and median decline in price was roughly 17% […]
J&J’s Ethicon wins lawsuit over hernia mesh
A New Jersey appeals court has thrown out a lawsuit against Johnson & Johnson (NYSE:JNJ) and its Ethicon unit because the woman who had mesh implanted to correct a hernia could not identify its manufacturer. Plaintiffs Deborah Kline and her husband, Jeffrey Derstine, sued the companies in 2014, alleging that the polypropylene mesh implanted in Kline’s […]
Is Medtronic eyeing LivaNova for a takeover?
Some industry analysts are speculating that Medtronic (NYSE:MDT) might want to acquire LivaNova (NSDQ:LIVN) for its neuromodulation business. A source told financial intelligence company Reorg last week that someone pitched the idea to Medtronic, which would divest LivaNova’s cardiovascular business and “certain MDT cardiac surgery products.” “Five sector advisors said such a deal would make sense as […]
Could an Apple Watch app reduce stroke risks? Apple and J&J think so
Johnson & Johnson (NYSE:JNJ) and Apple (NSDQ:AAPL) announced today that they’ve opened enrollment for the Heartline Study, which will look at the ability of Apple Watch heart health features to reduce stroke risks. The Janssen Pharmaceutical Cos. of Johnson & Johnson, in collaboration with Apple, are looking for U.S. residents over 65 who have an iPhone 6s […]
J&J’s Ethicon mostly fends off Intuitive Surgical’s robotic surgery patent challenge
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon has kept most of a surgical robotics tool patent intact after a Patent Trial and Appeal Board decision on a challenge from rival Intuitive Surgical (NSDQ:ISRG). The board’s decision, dated Feb. 18, involved an Ethicon patent for a “Shiftable Drive Interface for Robotically-Controlled Surgical Tool,” issued in 2013. Out of […]
DePuy Synthes and Orthofix settle customer-poaching lawsuit
Johnson & Johnson (NYSE:JNJ) unit DePuy Synthes has settled its lawsuit over alleged customer-poaching against Orthofix (NSDQ:OFIX) and a pair of former DePuy sales reps for an undisclosed amount. The confidential settlement comes nearly 11 months after DePuy filed suit in the U.S. District Court for Eastern Texas, alleging that its rival lured the reps and two […]
BREAKING: J&J ordered to pay $344m in California pelvic mesh case
A California judge ruled today that Johnson & Johnson and its Ethicon subsidiary must pay $344 million in penalties in a case claiming false and deceptive marketing of its pelvic mesh products for women. The California Department of Justice said it sued Johnson & Johnson in May 2016 after a years-long multistate investigation revealed the […]
Johnson & Johnson planning a robotic surgery reveal in May
Johnson & Johnson (NYSE:JNJ) appears to be preparing a preview of its robotic and digital surgery plans at a Medical Device Business Review Day that the company is planning May 13 in New York City. “We think it will provide a very clear, transparent kind of tangible evidence of not only the machines but also the […]
Johnson & Johnson misses the mark on Q4 revenue
Johnson & Johnson (NYSE:JNJ) today reported fourth-quarter earnings that beat the consensus forecast on Wall Street, but its sales numbers were slightly off amid declining medical device revenue. The New Brunswick, N.J.–based pharmaceutical, medical device and consumer products giant reported profits of $4.0 billion, or $1.50 per share, on sales of $20.7 billion for the three […]
